Private Equity
Toronto-based philanthropic fundraising platform Wisely has raised $1.5 million in a seed-stage financing, bringing its total funding so far to $2.1 million. The round was led by Canadian early-stage venture capital firm Ripple Ventures, with participation from Verstra Ventures and Maple Leaf Angels. Founded in 2017 by CEO Artiom Komarov, CTO Ryan Henry and COO Wes Moon, Wisely provides artificial intelligence-enabled technology to help charities, foundations, educational institutions and non-profit organizations more effectively pursue donations. The round's proceeds will be used by Wisely to expand its operations in the North American market.
2 min read · 25 July 2019
Ciara, a Germany-based virtual assistant for inside sales reps, has secured seven-digital seed funding UVC Partners led the round.
3 min read · 25 July 2019
Leafwire, a cannabis business network, has raised $1 million in seed funding. The investors included Network Ventures, Silverleaf Venture Partners, KEY Investment Partners and One East Partners.
2 min read · 25 July 2019
Rimot, a Dartmouth, Nova Scotia-based remote infrastructure monitoring company, has raised $1.2 million in financing. Canadian early-stage venture capital firm Innovacorp invested $500,000, with the rest coming from angel investors. Founded in 2016, Rimot offers turnkey remote monitoring and analytics to help business and government organizations ensure the reliability of critical equipment in the field and minimize downtime, maintenance costs and risk. Led by CEO Andrew Boswell, Rimot will use the round's proceeds to accelerate its growth in Canada and the United States.
2 min read · 25 July 2019
OSF Ventures has raised $75 million for its second venture fund. The fund will invest in new technology, devices and services that offer improved and more cost efficient health care.
3 min read · 25 July 2019
Salt Lake City-based Health Catalyst, a provider of data and analytics technology and services to healthcare organizations, has raised $182 million for its IPO after pricing its 7 million shares at $26 per share. The stock began trading July 25, 2019 on the NASDAQ under the ticker symbol "HCAT." Goldman Sachs, J.P. Morgan and William Blair are the lead underwriters. Health Catalyst's pre-IPO backers included OrbiMed, Sequoia Capital, Norwest Venture Partners, Sands Capital Ventures, UPMC Enterprises and Kaiser Permanente Ventures.
3 min read · 25 July 2019
Friendswood, Texas-based Castle Biosciences Inc, a dermatological cancer company, has raised $64 million for its IPO after pricing its 4 million shares at $16 per share. The stock began trading July 25, 2019 on the NASDAQ under the ticker symbol "CSTL." SVB Leerink and Baird are the lead underwriters. Castle Biosciences' pre-IPO backers included Industry Ventures, HealthQuest Capital and Mountain Group Partners.
2 min read · 25 July 2019
Athens, Georgia-based ArunA Bio Inc, a developer of neural exosomes for the treatment of neurodegenerative diseases, has raised $13 million in financing. The backers included Eshelman Ventures.
1 min read · 25 July 2019
Iowa-based VIDA Diagnostics Inc, which is focused on transforming pulmonary care through intelligence, has secured an undisclosed amount of funding. The investor was UnityPoint Health Ventures.
1 min read · 25 July 2019
Silicon Valley and Tel Aviv-based BGV, an early-stage venture firm, has closed its opportunity fund at $70 million. BGV invests in enterprise 4.0 opportunities in global markets.
3 min read · 25 July 2019
